Skip to main content
. 2018 Jun 13;13(6):e0196113. doi: 10.1371/journal.pone.0196113

Table 3. Results of the most parsimonious models for the groups of studies.

Group Mean structure estimate se ci.lb ci.ub Pval  
Case-Controls intrcpt 1.0023 0.0129 0.9771 1.0275 < .0001 I2
Region2 -0.1842 0.0065 -0.197 -0.1714 < .0001 97.5054
Region6 -0.1052 0.0074 -0.1196 -0.0907 < .0001 R2
Individual type CTR 0.0566 0.0069 0.0431 0.0701 < .0001 0.5229
GTC treatment intrcpt 0.9924 0.032 0.9297 1.055 < .0001 I2
Region2 -0.1475 0.0214 -0.1893 -0.1056 < .0001 96.8124
Region6 -0.0855 0.0295 -0.1434 -0.0276 0.0038 R2
treatment- 0.0259 0.0196 -0.0124 0.0643 0.1855 0.2623
Vertebral fractures intrcpt 0.9204 0.0357 0.8504 0.9904 < .0001 I2
Region2 -0.1592 0.0203 -0.1989 -0.1194 < .0001 95.7399
Region6 -0.0777 0.0152 -0.1075 -0.0479 < .0001 R2
FV- 0.0331 0.0137 0.0063 0.06 0.0156 0.2621

Reference categories for Region, case-control status, treatment status and vertebral fractures status are Region 1, Case, GCT treatment + and FV + respectively. Region1: Lumbar, Region 2: Femoral, Region 6: total hip. Individual type Case: cases, Individual type CTR: controls. GCT treatment+: group under treatment; GCT treatment-: group without treatment. FV+: group with fractures; FV: group without fractures. I2: Heterogeneity by means of Higgins’s tests

Abbreviation: GCT: glucocorticoid; ci.lb: confidence interval lower bound; ci.ub: confidence interval upper bound